News tagged with ovarian cancers
Related topics: cancer cells
Psychedelic trips aid anxiety treatments in study
(AP) -- The big white pill was brought to her in an earthenware chalice. She'd already held hands with her two therapists and expressed her wishes for what it would help her do.
Medicine & Health / Psychology & Psychiatry
Apr 23, 2010 |
4.5 / 5 (39) |
26
Scientists synthesize long-sought-after anticancer agent
A team of Yale University scientists has synthesized for the first time a chemical compound called lomaiviticin aglycon, leading to the development of a new class of molecules that appear to target and destroy cancer stem ...
Jan 31, 2011 |
4.8 / 5 (15) |
0
|
High meat diet may lead to early puberty for girls
(PhysOrg.com) -- Increased amounts of meat in children's diets may be part of the reason why girls go through puberty at a much younger age than they did 100 years ago, new research using the Children of the ...
Jun 11, 2010 |
4.9 / 5 (12) |
37
|
Scientists discover how to switch cancer 'protector' gene on
(PhysOrg.com) -- A new UCL study has revealed that a gene that normally protects against ovarian cancer is switched off in two-thirds of cases and switching it back on arrests tumour growth.
Jul 05, 2010 |
4.9 / 5 (9) |
2
|
'Trojan Horse' particle sneaks chemotherapy in to kill ovarian cancer cells
A common chemotherapy drug has been successfully delivered to cancer cells inside tiny microparticles using a method inspired by our knowledge of how the human immune system works. The drug, delivered in this way, reduced ...
Sep 12, 2011 |
5 / 5 (8) |
0
|
Magnetic Nanoparticles Remove Ovarian Cancer Cells from the Abdominal Cavity
A major complicating factor in the treatment of ovarian cancer is that malignant cells are often shed into the patient’s abdominal cavity. These cells can then spread to other tissues, seeding new tumors that make effective ...
Nanotechnology / Bio & Medicine
Jul 18, 2010 |
5 / 5 (7) |
0
|
Revolutionary therapy slows tumor growth in advanced breast cancer
The new drug olaparib has antitumour activity in carriers of the BRCA1 or BRCA2 gene mutations who have advanced ovarian or breast cancer, according to the findings of two proof-of-concept trials. Together with previous findings, ...
Jul 05, 2010 |
4.3 / 5 (7) |
0
|
Novel electronic biosensing technology could facilitate a new era of personalized medicine
The multi-welled microplate, long a standard tool in biomedical research and diagnostic laboratories, could become a thing of the past thanks to new electronic biosensing technology developed by a team of ...
Nanotechnology / Bio & Medicine
Sep 20, 2010 |
5 / 5 (6) |
0
|
Researchers raise concerns over the increasing commercialization of science
The increasing commercialisation of science is restricting access to vital scientific knowledge and delaying the progress of science, claim researchers in the British Medical Journal today.
Sep 17, 2010 |
5 / 5 (5) |
3
Tiny hitchhikers attack cancer cells: Gold nanostars first to deliver drug directly to cancer cell nucleus
Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that ...
Nanotechnology / Bio & Medicine
Apr 05, 2012 |
5 / 5 (4) |
0
|
Curcumin nanoparticles 'open up' resistant cancers
Pre-treatment with curcumin, a component of the spice turmeric, makes ovarian cancer cells more vulnerable to chemotherapy and radiotherapy. Researchers writing in BioMed Central's open access Journal of Ovarian Research found ...
Nanotechnology / Bio & Medicine
Apr 28, 2010 |
4.8 / 5 (4) |
0
|
US girls sweep Google kids science fair
Three US girls won the top prizes in a global science fair launched by Google for their projects on ovarian cancer, grilled chicken and indoor air quality, the Internet giant announced Tuesday.
Jul 12, 2011 |
4.8 / 5 (4) |
0
New route to killing cancer gets a test run
A targeted therapy that has generated excitement for its early success in breast cancer is now being tested in the Triangle on other cancers, including often-deadly ovarian tumors.
Jun 24, 2010 |
5 / 5 (3) |
0
Cancer scientists believe nanoparticles could accurately target tumors, avoiding side effects
In the past 40 years, scientists have learned a great deal about how cells become cancerous. Some of that knowledge has translated to new treatments, but most of the time doctors are forced to rely on standard ch ...
Nanotechnology / Bio & Medicine
Nov 18, 2010 |
5 / 5 (3) |
1
|
Mapping of protein inhibitors facilitates development of tailor-made anticancer agents
(PhysOrg.com) -- A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism ...
Feb 20, 2012 |
5 / 5 (3) |
0
|
